BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 603291)

  • 1. [Effect of levodopa on the arterial pressure and the metabolism of catecholamines in essential hypertension].
    Zaldívar HM; Monroy JR; Sánchez Torres G; Chávez Lara B; Serrano PA
    Arch Inst Cardiol Mex; 1977; 47(5):591-603. PubMed ID: 603291
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of catecholamine excretion, vanilmandelic acid and metanephrine in essential arterial hypertension: correlation with the pressure values].
    Pirrelli A; Pieri R; Dolce E
    Boll Soc Ital Cardiol; 1976; 21(10):1823-8. PubMed ID: 1031609
    [No Abstract]   [Full Text] [Related]  

  • 3. State of adrenergic and cholinergic systems in schizophrenia patients during psychopharmacotherapy.
    Krupenina LB; Vinogradov MV
    Neurosci Behav Physiol; 1985; 15(1):1-8. PubMed ID: 3923387
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction of arterial blood pressure in adult rats with inherited stress-induced arterial hypertension by enhancement of catecholamine metabolism in early postnatal period.
    Naumenko EV; Maslova LN; Markel AL
    Endocrinol Exp; 1990 Mar; 24(1-2):241-8. PubMed ID: 2361463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [State of the adrenergic and cholinergic systems of schizophrenic patients during the process of psychopharmacotherapy].
    Krupenina LB; Vinogradov MV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):737-45. PubMed ID: 6106335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic fate of levodopa in man and animals.
    Louis WJ; Doyle AE; Sampson RG
    Clin Exp Pharmacol Physiol; 1974; 1(4):341-6. PubMed ID: 4459002
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of catecholamine metabolism in two hereditary forms of dystonia.
    Wotten GF; Eldridge R; Gordon EK; Axelrod J
    Trans Am Neurol Assoc; 1973; 98():245-7. PubMed ID: 4784942
    [No Abstract]   [Full Text] [Related]  

  • 8. [Excretion of catecholamines, their precursor DOPA and vanilmandelic acid in patients with peptic ulcer].
    Kravchenko TV; Sulima TA
    Vrach Delo; 1983 Aug; (8):85-7. PubMed ID: 6415922
    [No Abstract]   [Full Text] [Related]  

  • 9. Excretion of catecholamines in relatives of patients with familial neuroblastoma.
    Piöchl E; Käser H; Klein H
    Cancer Res; 1976 Jan; 36(1):10-12. PubMed ID: 1247989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma renin activity and urinary excretion of catecholamines and their metabolites in patients with primary arterial hypertension treated with metoprolol].
    Wocial B; Januszewicz W; Sznajderman M; Cybulska I; Brym E; Czerniewska E
    Pol Tyg Lek; 1983 Apr; 38(14):439-42. PubMed ID: 6356082
    [No Abstract]   [Full Text] [Related]  

  • 11. [Letter: Narcolepsy. Suppression of paradoxical sleep by L-dopa].
    Gilbert JC; Willer JC; Bernheim-Chatelain C; Ecoffet M; Jaillon P
    Nouv Presse Med; 1976 May; 5(20):1309-10. PubMed ID: 180496
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between serum dopamine-beta-hydroxylase activity, catecholamine metabolism, and hemodynamic changes during paroxysmal hypertension in quadriplegia.
    Naftchi NE; Wooten GF; Lowman EW; Axelrod J
    Circ Res; 1974 Dec; 35(6):850-61. PubMed ID: 4430080
    [No Abstract]   [Full Text] [Related]  

  • 13. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
    Borrello G
    Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenal response in the pathogenesis of arterial hypertension in workers exposed to high noise levels.
    Cavatorta A; Falzoi M; Romanelli A; Cigala F; Riccò M; Bruschi G; Franchini I; Borghetti A
    J Hypertens Suppl; 1987 Dec; 5(5):S463-6. PubMed ID: 3481819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolism of peripheral catecholamines and indole amines in healthy persons. Clinico-biochemical correlates].
    Krzyzowski J; Lewicka-Wysocka H; Lukaszewska B; Marcjan K; Pacyna M; Pietruszewska I; Roguska E; Stencka K
    Pol Tyg Lek; 1981 Mar; 36(11):417-21. PubMed ID: 6167972
    [No Abstract]   [Full Text] [Related]  

  • 16. Pheochromocytoma: advances in diagnosis and treatment.
    Pertsemlidis D; Gitlow SE; Kark AE
    Surg Annu; 1972; 4():345-57. PubMed ID: 4589383
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in the excretion of catecholamines and their metabolites in patients with essential hypertension during sodium intake restriction.
    Wocial B; Januszewicz W; Chodakowska J; Feltynowski T
    Cor Vasa; 1981; 23(3):222-8. PubMed ID: 6790225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Excretion of vanillic acid and homovanillic acid and tissue distribution of catecholamines and their metabolites in mice with various levels of pigmentation].
    Orgacka H; Zbytniewski Z
    Endokrynol Pol; 1991; 42(3):471-9. PubMed ID: 1364497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudopheochromocytoma in Parkinson disease and depression].
    Jähnel M
    Psychiatr Prax; 2003 May; 30 Suppl 2():S64-5. PubMed ID: 14509040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Catecholamine, DOPA and vanilmandelic acid excretion in healthy subjects and depression patients of presenile age].
    Kryzhanovskaia LA; Usherenko LS
    Fiziol Zh; 1978; 24(4):511-8. PubMed ID: 680253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.